Category: Globally Aware

From Passion Health Primary Care – Timely, Regionally-Relevant & Globally InformedFrom Passion Health Primary Care – Timely, Regionally-Relevant & Globally Informed

National Updates Major ACA Subsidy Risk for Next YearHealth insurance experts warn that expiration of enhanced tax credits under the Affordable Care Act could push premiums sharply higher for many

From Passion Health Primary CareFrom Passion Health Primary Care

National Updates The U.S. is exiting a 43-day federal government shutdown: Donald Trump signed the funding bill on November 12, restoring many federal health‐ and food‐assistance programs. Reuters Discussions are

From Passion Health Primary Care – Current, Verified & Clinically UsefulFrom Passion Health Primary Care – Current, Verified & Clinically Useful

National Updates Food & Drug Administration (FDA) Moves to Remove Black-Box Warnings on Menopause Hormone TherapyThe FDA announced the removal of strong black-box warnings from over 20 menopause hormone therapy

From Passion Health Primary Care – Accurate, Up-to-Date, and Clinically OrientedFrom Passion Health Primary Care – Accurate, Up-to-Date, and Clinically Oriented

National Updates U.S. Department of Health and Human Services Removes “Black Box” Warnings for Hormone Replacement TherapyHHS announced that the U.S. Food & Drug Administration is initiating removal of broad

From Passion Health Primary Care – Trusted, Current & ActionableFrom Passion Health Primary Care – Trusted, Current & Actionable

National Updates New U.S. Dietary Guidelines Coming in DecemberFood and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) will release updated dietary guidelines this December. The upcoming recommendations will

From Passion Health Primary Care – Trusted, Regionally Relevant & Community-FocusedFrom Passion Health Primary Care – Trusted, Regionally Relevant & Community-Focused

National Updates The Food and Drug Administration (FDA) has expanded the approved use of Caplyta (brand name) from Johnson & Johnson/Intra‑Cellular Therapies for adults with major depressive disorder as an

From Passion Health Primary Care – Trusted, Timely, Region-FocusedFrom Passion Health Primary Care – Trusted, Timely, Region-Focused

National Updates Food and Drug Administration Clears Rare-Disease Drug Amid Reviewer ObjectionsThe FDA approved a new treatment for a rare genetic condition despite significant internal reviewer objections regarding cost-effectiveness and

From Passion Health Primary Care – Trusted, Relevant, and Regionally FocusedFrom Passion Health Primary Care – Trusted, Relevant, and Regionally Focused

National Updates The open­enrollment period for the Affordable Care Act marketplace has officially begun on November 1; many states report significant premium increases as enhanced subsidies are set to expire.

From Passion Health Primary Care – Trusted, Timely, Region-FocusedFrom Passion Health Primary Care – Trusted, Timely, Region-Focused

National Updates The American Academy of Pediatrics (AAP) has issued new guidance advising against the routine use of Leucovorin (a form of vitamin B9) in children with autism, citing insufficient